Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8480325 | 8644631 | I | 8480325-3 | 20120401 | 20120621 | 20120630 | EXP | FR-AMGEN-FRASP2012039665 | AMGENSAFETY | 73 | YR | F | Y | 20120630 | OT | FRANCE |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
8480325 | 1020135218 | C | CACIT D3 | 2 | UNK | ||||||
8480325 | 1020135219 | C | ALENDRONATE SODIUM | 1 | UNK | ||||||
8480325 | 1020135215 | C | EUPRESSYL /00631801/ | 2 | UNK | ||||||
8480325 | 1020135212 | C | METHOTREXATE | 1 | 15 MG, UNK | ||||||
8480325 | 1020135214 | C | VALSARTAN AND HYDROCHLOROTHIAZIDE | 1 | UNK | ||||||
8480325 | 1020135216 | C | CELIPROLOL | 2 | UNK | ||||||
8480325 | 1020135211 | PS | ENBREL | 1 | SUBCUTANEOUS | 50 MG, UNK | |||||
8480325 | 1020135213 | C | AMLODIPINE BESYLATE | 1 | UNK | ||||||
8480325 | 1020135217 | C | NEXIUM | 1 | UNK | ||||||
8480325 | 1020135220 | C | ASPEGIC 1000 | 1 | UNK | ||||||
8480325 | 1020135221 | C | TRAMADOL HCL | 1 | UNK | ||||||
8480325 | 1020135222 | C | FOLIC ACID | 1 | UNK |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
8480325 | 1020135211 | RHEUMATOID ARTHRITIS |
Outcome of event
Event ID | OUTC COD |
---|---|
8480325 | HO |
Reactions reported
Event ID | PT |
---|---|
8480325 | FALL |
8480325 | ERYSIPELAS |
8480325 | HYGROMA COLLI |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
8480325 | 1020135211 | 20080101 | 20120521 |